Xinyi Shen, MPH
Postgraduate AssociateAbout
Copy Link
Titles
Postgraduate Associate
Biography
PhD candidate in EHS at YSPH
MPH in CDE at YSPH, class of 2021
Last Updated on August 15, 2024.
Departments & Organizations
Education & Training
- MPH
- Yale School of Public Health (2021)
Research
Copy Link
Overview
Sex differences in cancer metabolism and drug response using bioinformatics approaches.
ORCID
0000-0001-6519-9311
Research at a Glance
Yale Co-Authors
Frequent collaborators of Xinyi Shen's published research.
Publications Timeline
A big-picture view of Xinyi Shen's research output by year.
Caroline Helen Johnson, PhD
Sajid A Khan, MD, FACS, FSSO
Lingeng Lu, MD, PhD
Andrew DeWan, PhD, MPH
Joanna Gibson, MD, PhD
Jun Lu, PhD
16Publications
689Citations
Publications
2025
MoEcho: Exploiting Side-Channel Attacks to Compromise User Privacy in Mixture-of-Experts LLMs
Ding R, Xu T, Shen X, Ding A, Fei Y. MoEcho: Exploiting Side-Channel Attacks to Compromise User Privacy in Mixture-of-Experts LLMs. 2025, 2159-2173. DOI: 10.1145/3719027.3765174.Peer-Reviewed Original ResearchCitationsConceptsVision-language modelsUser privacySide-channelInference attacksReconstruction attacksAttack surfaceCompromise users' privacySensitive user dataSide-channel attacksMulti-modal learningEnd-to-end experienceNatural language processingMixture-of-expertsEnd-to-endPrivacy threatsSecurity analysisComputer visionPrivacy breachesUser dataInput tokensTransformer architectureModern AIPrivate inputsComputing platformHardware executionDynamic clinical trial success rates for drugs in the 21st century
Zhou Y, Zhang Y, Xu H, Chen Z, Huang S, Li Y, Fu J, Zhang H, Zhao D, Lian X, Zhou Y, Shen X, Liu K, Qiu Y, Wang Y, Xie W, Han L, Dai H, Zhu F. Dynamic clinical trial success rates for drugs in the 21st century. Nature Communications 2025, 16: 9537. PMID: 41162353, PMCID: PMC12572394, DOI: 10.1038/s41467-025-64552-2.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsSex-specific effects of exogenous asparagine on colorectal tumor growth, 17β-estradiol levels, and aromatase
Aladelokun O, Benitez K, Wang Y, Jain A, Berardi D, Maroun G, Shen X, Roper J, Gibson J, Sumigray K, Khan S, Johnson C. Sex-specific effects of exogenous asparagine on colorectal tumor growth, 17β-estradiol levels, and aromatase. Pharmacological Research 2025, 215: 107736. PMID: 40228761, PMCID: PMC12100670, DOI: 10.1016/j.phrs.2025.107736.Peer-Reviewed Original ResearchCitationsConceptsTumor-specific survivalColorectal cancerTumor growthR2G2 miceIncreased serum estradiol levelsSerum estradiol levelsSub-populations of macrophagesAssociated with cancer prognosisSuppressed tumor growthColorectal tumor growthExogenous asparagineColorectal cancer developmentColorectal cancer cellsNegative feed-back effectEstradiol levelsGlutamate levelsSex-related differencesSex-specific effectsMale miceCancer prognosisAsparagine supplementationCancer progressionMiceDecreased numberTumor
2024
OncoSexome: the landscape of sex-based differences in oncologic diseases
Shen X, Zhang Y, Li J, Zhou Y, Butensky S, Zhang Y, Cai Z, DeWan A, Khan S, Yan H, Johnson C, Zhu F. OncoSexome: the landscape of sex-based differences in oncologic diseases. Nucleic Acids Research 2024, 53: d1443-d1459. PMID: 39535034, PMCID: PMC11701605, DOI: 10.1093/nar/gkae1003.Peer-Reviewed Original ResearchCitationsAltmetricAsparagine synthetase and G‐protein coupled estrogen receptor are critical responders to nutrient supply in KRAS mutant colorectal cancer
Lu L, Zhang Q, Aladelokun O, Berardi D, Shen X, Marin A, Garcia‐Milian R, Roper J, Khan S, Johnson C. Asparagine synthetase and G‐protein coupled estrogen receptor are critical responders to nutrient supply in KRAS mutant colorectal cancer. International Journal Of Cancer 2024, 156: 52-68. PMID: 39039782, PMCID: PMC11537827, DOI: 10.1002/ijc.35104.Peer-Reviewed Original ResearchCitationsConceptsG protein-coupled estrogen receptor 1KRAS mutant colorectal cancerAsparagine synthetase expressionMutant colorectal cancerColorectal cancerAsparagine synthetaseG-protein coupled estrogen receptor 1 expressionG protein-coupled estrogen receptorWild-typeAssociated with poor overall survivalAdvanced stage tumorsKRAS wild-typeProtective effect of estradiolEffects of estradiolPoor overall survivalEstrogen receptor 1Expression of asparagine synthetasePresence of estradiolIncreased caspase-3 activityDepletion inhibited cell growthColon cancer cohortNutrient supplyAdvanced tumorsOverall survivalStage tumors
2023
TheMarker: a comprehensive database of therapeutic biomarkers
Zhang Y, Zhou Y, Zhou Y, Yu X, Shen X, Hong Y, Zhang Y, Wang S, Mou M, Zhang J, Tao L, Gao J, Qiu Y, Chen Y, Zhu F. TheMarker: a comprehensive database of therapeutic biomarkers. Nucleic Acids Research 2023, 52: d1450-d1464. PMID: 37850638, PMCID: PMC10767989, DOI: 10.1093/nar/gkad862.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsClinical practiceTherapeutic biomarkersTherapy-induced toxicityClinical outcomesPredictive biomarkersPharmacodynamic biomarkersClinical managementPrognostic biomarkerSafety biomarkersClinical developmentPatient statusPharmacological effectsMonitoring biomarkerTherapyBiomarkersAnticancer therapyDrug developmentDrug discoveryDisease classesStatusDatabaseTTD: Therapeutic Target Database describing target druggability information
Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F. TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Research 2023, 52: d1465-d1477. PMID: 37713619, PMCID: PMC10767903, DOI: 10.1093/nar/gkad751.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsDiscovery of decreased ferroptosis in male colorectal cancer patients with KRAS mutations
Yan H, Talty R, Jain A, Cai Y, Zheng J, Shen X, Muca E, Paty P, Bosenberg M, Khan S, Johnson C. Discovery of decreased ferroptosis in male colorectal cancer patients with KRAS mutations. Redox Biology 2023, 62: 102699. PMID: 37086630, PMCID: PMC10172914, DOI: 10.1016/j.redox.2023.102699.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsKRAS mutant tumorsMale CRC patientsCRC patientsMale patientsKRAS mutationsMutant tumorsOverall survivalMale colorectal cancer patientsKRAS wild-type tumorsAberrant tumor metabolismColorectal cancer patientsCRC patient cohortsColorectal cancer casesFerroptosis-related genesWild-type tumorsNovel potential avenuesNormal colon tissuesPoor OSKRAS statusAdverse outcomesCRC cellsPatient cohortCancer patientsType tumorsCancer casesEarly-Onset Colorectal Cancer Somatic Gene Mutations by Population Subgroups.
Shen X, DeWan A, Johnson C. Early-Onset Colorectal Cancer Somatic Gene Mutations by Population Subgroups. Cancer Discovery 2023, 13: 530-531. PMID: 36855917, DOI: 10.1158/2159-8290.cd-22-1464.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsIdentifying Sex-Specific Cancer Metabolites and Associations to Prognosis
Shen X, Ma S, Khan S, Johnson C. Identifying Sex-Specific Cancer Metabolites and Associations to Prognosis. Learning Materials In Biosciences 2023, 271-299. DOI: 10.1007/978-3-031-44256-8_11.Peer-Reviewed Original ResearchConceptsMetabolomics dataSurvival analysisCancer metabolitesColorectal cancerCox proportional hazards regression analysisProportional hazards regression analysisHazards regression analysisSex-specific associationsClinical dataCancer patientsCancer prognosisCancerMetabolomicsMultiple comparisonsPrognosisAnalytical methodSurvivalOncology studiesPatientsAlternative analytical approachRegression analysisSex-SpecificMetabolitesSex interactionAssociation
News
Copy Link
News
Get In Touch
Copy Link
Contacts
Email